These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25433721)

  • 1. Perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor.
    Sugita Y; Terasaki M; Nakashima S; Ohshima K; Morioka M; Abe H
    Brain Tumor Pathol; 2015 Jan; 32(1):41-8. PubMed ID: 25433721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells.
    Venetz D; Ponzoni M; Schiraldi M; Ferreri AJ; Bertoni F; Doglioni C; Uguccioni M
    Int J Cancer; 2010 Nov; 127(10):2300-12. PubMed ID: 20872671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.
    Fujii A; Ohshima K; Hamasaki M; Makimoto Y; Haraoka S; Utsunomiya H; Okazaki M; Kikuchi M
    Int J Oncol; 2004 Mar; 24(3):529-38. PubMed ID: 14767537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.
    Brunn A; Montesinos-Rongen M; Strack A; Reifenberger G; Mawrin C; Schaller C; Deckert M
    Acta Neuropathol; 2007 Sep; 114(3):271-6. PubMed ID: 17641901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.
    Montesinos-Rongen M; Küppers R; Schlüter D; Spieker T; Van Roost D; Schaller C; Reifenberger G; Wiestler OD; Deckert-Schlüter M
    Am J Pathol; 1999 Dec; 155(6):2077-86. PubMed ID: 10595937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes regulating the B cell receptor pathway are recurrently mutated in primary central nervous system lymphoma.
    Montesinos-Rongen M; Schäfer E; Siebert R; Deckert M
    Acta Neuropathol; 2012 Dec; 124(6):905-6. PubMed ID: 23138649
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of cyclooxygenase-2 and vascular endothelial growth factor in primary central nervous system lymphomas.
    Sugita Y; Komatani H; Ohshima K; Shigemori M; Nakashima A
    Oncol Rep; 2007 Sep; 18(3):617-22. PubMed ID: 17671709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
    Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
    Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
    Courts C; Montesinos-Rongen M; Brunn A; Bug S; Siemer D; Hans V; Blümcke I; Klapper W; Schaller C; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2008 Jul; 67(7):720-7. PubMed ID: 18596541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas.
    Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
    Oncology; 2006; 70(3):212-21. PubMed ID: 16809940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin repertoire of primary lymphomas of the central nervous system.
    Montesinos-Rongen M; Purschke F; Küppers R; Deckert M
    J Neuropathol Exp Neurol; 2014 Dec; 73(12):1116-25. PubMed ID: 25383641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of p27 expression in primary central nervous system lymphoma.
    Kunishio K; Nagao S
    Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
    Pimenta EM; De S; Weiss R; Feng D; Hall K; Kilic S; Bhanot G; Ganesan S; Ran S; Barnes BJ
    Immunol Cell Biol; 2015; 93(5):486-99. PubMed ID: 25533286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications.
    Kleinschmidt-DeMasters BK; Damek DM; Lillehei KO; Dogan A; Giannini C
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1103-11. PubMed ID: 18957891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic characterization of primary diffuse large B-cell lymphomas in the central nervous system.
    Li J; Okamoto H; Yin C; Jagannathan J; Takizawa J; Aoki S; Gläsker S; Rushing EJ; Vortmeyer AO; Oldfield EH; Yamanaka R; Zhuang Z
    J Neurosurg; 2008 Sep; 109(3):536-46. PubMed ID: 18759588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.